35,36 At the final examination day (day 42), tumours with an estimated size < 30 mm3 were defined as ‘rejected’ and the final rejected ratios were calculated. In some selected experiments, P815 and B7-H3/P815 (5 × 104) cells were injected into BALB/c nude Palbociclib cell line mice and tumour volumes were evaluated. To deplete CD4+, CD8+, or both T cells, 0·5 mg of anti-CD4 (GK1.5), anti-CD8 (53-6.72), or both mAbs were administrated i.p.
on days − 5, − 1 and 3. In experiments examining the effects of anti-B7-H3 or anti-TLT-2 mAb, 200 μg each of anti-B7-H3 (MIH35), anti-TLT-2 (MIH49) mAb, or control immunoglobulin was injected i.p. every other day after tumour inoculation. For isolating tumour-infiltrating
lymphocytes (TIL), the skin with a small tumour mass at the parental SCCVII or B7-H3/SCCVII tumour-inoculated sites was resected after 7 days and single-cell Volasertib price suspensions were obtained by digestion with collagenase I (400 U/ml; Sigma, St Louis, MO), DNase (10 U/ml; Wako, Tokyo, Japan) and hyaluronidase (2·5 U/ml; Sigma), followed by a density gradient.37 The cells were then subjected to flow cytometry. OT-1 CD8+ T cells (1 × 106 cells) were co-cultured with equal numbers of B7-H3/E.G7 for 24 hr and then expression of TLT-2, CD8, CD3 and CD69 or CD25 was analysed by flow cytometry. For experiments to see the effects of cytokines on TLT-2 expression, CD8+ T cells (8 × 105 cells/well) from naive B6 mice were stimulated with immobilized anti-CD3 mAb (145-2C11, 5 μg/ml) in the presence of either interleukin-2 (IL-2; 10 ng/ml), IL-10 (20 ng/ml), tumour necrosis factor-α Rutecarpine (TNF-α; 40 ng/ml), IFN-γ (10 ng/ml) or transforming growth factor-β (TGF-β;
10 ng/ml) in 24-well plates for 3 days. The cells were collected and subjected to flow cytometric analyses for TLT-2 expression. All cytokines were obtained from eBioscience or BD Pharmingen. A co-stimulation assay using Fcγ receptor-bearing P815 cells and sub-optimal doses of anti-CD3 mAb has been used to evaluate co-signal function of various B7 and TNF family molecules.28,33,38–41 We examined the effect of B7-H3 transduction in P815 cells on anti-CD3 mAb-induced CD4+ or CD8+ T-cell responses including proliferative responses, cytokine production and cytotoxicity. P815 cells expressed endogenously low levels of B7-H3 but the transduction of B7-H3 induced dramatically higher levels (∼ 50-fold; Fig. S1 and ref. 28). Splenic CD4+ or CD8+ T cells were co-cultured with either parental P815 or B7-H3/P815 cells in the presence of a suboptimal dose of anti-CD3 mAb.